3-amino-3-arylpropan-1-ol-compounds, their preparation and use

Details 3-amino-3-arylpropan-1-ol-compounds, their preparation and use 3-amino-3-arylpropan-1-ol-compounds, their preparation and use

2007-03-27

2007-03-27

Barts, Samuel (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S445000, C514S473000, C564S391000, C564S384000, C564S389000, C564S336000, C560S073000, C549S065000, C549S479000

Reissue Patent

active

10659680

ABSTRACT:
3-amino-3-arylpropan-1-ol compounds corresponding to the formula Iin which R1to R5, A and X have the meanings according to claim 1, and their preparation and use as medicaments.

REFERENCES:
patent: 3937818 (1976-02-01), Fletcher et al.
patent: 3975436 (1976-08-01), Fletcher et al.
patent: 4017637 (1977-04-01), Yardley et al.
patent: 4143158 (1979-03-01), Lien et al.
patent: 1043307 (2000-10-01), None
European Search Report.
Carlson et al., “Improved Titanium Tetrachloride Procedure for Enamine Sunthesis. II. Scope of the Reaction”,Acta Chemica Scandinavica B 38,1984, pp. 49-53.
Risch et al., “Additions of Enamines to Iminium Ions”,Houben-WeylE21b, 1995, pp. 1925-1929.
Risch et al., “Diastereomerenreine Mannich-Based durch Addition von Enaminen an ternäre Iminiumsalze”,Agnew. Chem,106, 1994, pp. 2531-2533.
Arend et al., “A Simple and Highly Diastereoselective One-Pot Synthesis of Mannich-Bases”,Synlett,Jun. 17, 1997, pp. 974-976.
Winterfeldt, “Applications of Diisobutylaluminium Hydride (DIBAH) and Triisobutylaluminium (TIBA) as Reducing Agents in Organic Synthesis”,Synthesis,Oct. 1975, pp. 617-630.
Hendershot et al., “Antagonism of the Frequency of Phenylquinone-Induced Writhing in the Mouse by Weak Analgesics and Nonanalgesics”,J. Pharmacol. Exp. Ther.,1959, pp. 237-240.
Schoemaker et al., “[3H]Diltiazem Binding to Calcium Channel Antagonists Recognition Sites in Rat Cerebral Cortex”,European Journal of Pharmacology111, 1985, pp. 273-277.
Gray et al., “The Isolation of Nerve Endings from Brain: an Electron-Microscopic Study of Cell Fragments Derived by Homogenization and Centrifugation”,J. Anat.96, 1962, pp. 79-88.
Pauwels et al., “[3H]Batrachotoxinin A 20-α-Benzoate Binding to Sodium Channels in Rat Brain: Characterization and Pharmacological Significance”,European Journal of Pharmacology124, 1986, pp. 291-298.
Cheng et al., “Relationship Between the Inhibition Constant (KI) and the Concentration of Inhibitor Which Causes 50 per cent Inhibition (I50) of an Enzymatic Reaction”,Biochem. Pharmacology,vol. 22, 1973, pp. 3099-3108.
Lineweaver et al., “The Determination of Enzyme Dissociation Constants”,J. Am. Chem. Soc.,vol. 56, 1934, pp. 658-666.
Lieberman, “The Use of the Disproportion of Esters of 2-Propanenitronic Acid to Convert Halides to Carbonyl Compounds and Benzaldehyde to Benzamides”,J. Am. Chem. Soc.77, 1955, pp. 1114-1116.
Goodman & Gilman, “The Pharmacological Basis of Therapeutics”, 9thEdition, Section III, Chapter 23, (1991).
Larock, “Comprehensive Organic Transformations”, VCH Publishers, (1989), pp. 966-973.

Affiliated with

Also associated with

Rating

3-amino-3-arylpropan-1-ol-compounds, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-amino-3-arylpropan-1-ol-compounds, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-amino-3-arylpropan-1-ol-compounds, their preparation and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3796901